Vikram S.

Vikram S. is an experienced executive in bioprocess development, currently serving as Executive Director at Denali Therapeutics since April 2019, where leadership encompasses the Bioprocess Development team, overseeing various stages of Cell Line Development, Upstream, Downstream, and Conjugation Process Development for both early and late-stage programs. Prior roles include Senior Director and Director of Bioprocess Development at AbbVie, where Vikram led teams focused on pioneering methods for antibody drug conjugate therapies and downstream purification processes. Experience also includes establishing ADC and purification capabilities at Stemcentrx, Inc., and contributing to antibody drug conjugate development at Genentech. Vikram's career began at IBM Almaden Research Center as a Research Assistant, with academic credentials comprising a Master’s degree in Chemical Engineering and a Bachelor’s degree in Biological Systems and Chemistry from San José State University.